The rise in healthcare spending and the surge in interest in living a better life are expected to drive up adoption of Immunohistochemistry.
The immunohistochemistry market is expected to grow due to an increase in chronic diseases. As value-based healthcare solutions become more popular, it is expected that demand for immunohistochemistry will skyrocket.
The immunohistochemistry market share is expected to grow as the number of patients with cancer, infectious diseases, and cardiovascular disorders increases, all of which use immunohistochemistry for diagnosis.
The rapid spread of infectious diseases presents a challenge for medical professionals in developing drugs for such unidentified diseases. Immunohistochemistry demand for such diseases is expected to drive immunohistochemistry market growth.
Get a Sample PDF Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14808
According to the International Diabetes Federation, 463 million people aged 20 to 79 have diabetes worldwide in 2019, with that figure expected to rise to nearly 700 million by 2045.
Immunohistochemistry market growth is expected to be driven by increased R&D in immunohistochemistry-based techniques in the coming years.
Furthermore, the use of immunohistochemistry is expected to increase over the projected period due to an increase in the incidence and prevalence of chronic diseases such as cancer, in which proteins are expected to play a significant role. The immunohistochemistry industry’s short-term growth is expected to be hampered by unfavourable reimbursement regulations.
Key Takeaways from Market Study
- Because antibodies are so important in disease diagnosis and medication testing, the antibodies segment is expected to dominate the immunochemistry market in 2021, accounting for more than 41% of global revenue.
- The diagnostics application sector accounted for roughly 70% of revenue in 2021, and this segment is expected to lead throughout the forecast period.
- Hospitals and diagnostic laboratories will account for more than 71% of total revenue in 2021, dominating the immunochemistry market.
- In 2021, North America is expected to dominate the immunochemistry market, accounting for more than 39% of global sales.
- During the forecast period, Asia Pacific is expected to have the fastest CAGR. This is largely due to the increased geographic presence of global players in Asian markets.
“Increased automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions, are expected to drive immunohistochemistry market share significantly during the forecast period. The use of immunohistochemistry in disease diagnosis has grown significantly as IHC methods have advanced.” Analyst, Future Market Insights
Competitive Landscape
Key immunohistochemistry market players are developing cutting-edge products that will drive immunohistochemistry market growth.
The introduction of these clinical diagnostic markers could aid in the advancement of early cancer medication development in the immuno-oncology field. Due to R&D advancements, the immunohistochemistry market is expected to expand at a faster rate during the forecast period.
The following companies are among the major players in the global immunohistochemistry market: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA; Danaher Corporation; PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB; Abcam plc., Agilent Technologies, Inc.
For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14808
Key Segments
By Product:
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining System
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
By Application:
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
By End-use:
- Hospitals & Diagnostic Laboratories
- Research Institutes
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- MEA
Recent Developments in Immunohistochemistry Market:
- The FDA approved Roche’s VENTANA MMR RxDx companion diagnostic test in August 2021 for solid tumours that lack the MMR pathway. The test determines who is eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.
- In August 2021, Agilent received a CE-IVD mark in Europe for its PD-L1 IHC 22C3 pharmDx assay for identifying oesophageal cancer patients for treatment with KEYTRUDA.
- In January 2021, Biocare Medical LLC introduced the ONCORE Pro, a fully automated in vitro diagnostic benchtop system for In-situ Hybridization (ISH) and IHC applications.
- Abcam and Shuwen Biotech (Shuwen) formed a strategic partnership in January 2021 to develop and market Companion Diagnostics (CDx). Abcam will supply recombinant rabbit monoclonal antibodies to Shuwen Biotech for additional immunohistochemistry, according to the agreement.
Click on the Below Link to Buy this Report@ https://www.futuremarketinsights.com/checkout/14808
Table of Content
- Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
- Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
- Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
TOC to be Continued…
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs